封面
市场调查报告书
商品编码
1744564

2032 年失智症护理产品市场预测:按产品、分销管道、最终用户和地区进行的全球分析

Dementia Care Products Market Forecasts to 2032 - Global Analysis By Product (Memory Exercise & Activity Products, Medication Management Products, Daily Reminder Products and Other Products), Distribution Channel, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,全球失智症护理产品市场预计在 2025 年达到 2,707 万美元,到 2032 年将达到 4,761 万美元,预测期内的复合年增长率为 8.4%。

失智症护理产品是专门为支持和改善失智症患者生活品质而设计的工具、设备和辅助工具。这些产品旨在提升居家和护理环境中的安全性、独立性、舒适性和认知支持。常见产品包括记忆辅助器、定向手錶、自适应服装、GPS追踪器、感官治疗工具和易于使用的家居用品。这些产品可以减少思维混乱、防止走失、控制焦虑并协助日常生活活动。失智症照护产品也能让照护任务更轻鬆、更有效率,进而为看护者提供支持,最终提升认知衰退患者的整体福祉与尊严。

根据世界卫生组织(WHO)的数据,2023年全球将有约5,500万人罹患失智症,预计2024年将增加至5,700万人。

全球失智症盛行率上升

全球失智症盛行率的上升正推动失智症护理产品市场的快速成长。随着越来越多的个人和家庭面临记忆力衰退和认知能力下降的挑战,对创新有效的解决方案的需求也日益增长,这些解决方案旨在提升他们的生活品质并方便护理。这种激增反过来又推动了辅助器具、安全工具和日常生活辅助设备领域的研究、产品开发和技术进步。因此,市场正呈现积极向上的势头,吸引着投资,并在全球范围内提升了对失智症护理需求的认识。

专业产品高成本

失智症照护专用产品的高昂成本对许多家庭来说是一个重大障碍,限制了他们获得必要的工具和技术。这种经济负担降低了市场需求,并减缓了创新和产品开发。此外,高昂的价格可能会扩大健康差距,因为低收入者难以负担高品质的照护解决方案。结果,市场成长受到阻碍,由于限制了先进专业产品的供应和采用,失智症护理的整体品质可能会下降。

护理产品的技术进步

护理产品的技术进步正在稳步改变失智症护理产品市场,增强患者安全性、提高看护者效率并实现个人化护理。穿戴式健康监测器、GPS 追踪设备和人工智慧认知辅助设备等技术创新有助于早期发现和更好地管理症状。这些技术也减轻了看护者的负担,提高了失智症患者的独立性。因此,对智慧技术整合解决方案的需求正在推动市场成长,并鼓励失智症护理领域的进一步创新。

监管挑战

监管挑战是失智症护理产品市场发展的一大障碍,导致产品认证延迟和开发成本增加。严格的合规要求阻碍了创新,并限制了先进护理解决方案的采用。这些障碍阻碍了投资,减缓了市场成长,并限制了患者获得有效产品的管道。此外,地区间监管差异也使全球分销变得复杂,进一步阻碍了失智症护理关键技术的及时取得和应用。

COVID-19的影响

新冠疫情 (COVID-19) 疫情扰乱了供应链,限制了患者获得基本护理用品,对失智症护理产品市场造成了重大衝击。封锁措施和医疗体系的压力导致面对面援助减少,从而增加了对居家照护解决方案的需求。然而,随着人们对失智症弱势群体的认知度不断提高,远端监控和辅助技术的创新和应用也随之兴起,最终重塑了护理服务模式,并加速了疫情后的市场成长。

认知训练工具市场预计将成为预测期内最大的市场

认知训练工具细分市场提供非侵入式解决方案,以增强认知功能并减缓疾病进展,预计将在预测期内占据最大的市场占有率。这些工具支持记忆力、注意力和解决问题的能力,补充医疗并促进独立生活。它们在家庭和机构中的日益普及反映了人们对非药物干预措施日益增长的认识。随着失智症盛行率的上升,对实证和创新认知训练解决方案的需求正在推动市场成长,并形成一种更全面的失智症护理方法。

预计医院部门在预测期内将以最高复合年增长率成长

由于对先进护理解决方案的需求,预计医院领域将在预测期内实现最高成长率。医院是诊断、治疗和长期照护的关键枢纽,促进了认知辅助设备、监测设备和个人护理工具等创新产品的采用。医院对病人安全、标准化护理和看护者支援的重视,进一步推动了市场成长。此外,基于医院的研究计划和合作正在加速产品开发,提高整体失智症护理的品质和可及性。

占比最大的地区:

由于认知度的提高、老年人口的增长以及医疗基础设施的改善,预计亚太地区将在预测期内占据最大的市场占有率。辅助科技的创新和政府的支持性政策正在增强病患照护和独立性。区域公司加强投资力度以及与全球公司的合作正在提升产品的可用性和定价。这些发展不仅改善了失智症患者的生活质量,也全部区域创造了巨大的经济和就业机会。

复合年增长率最高的地区:

在预测期内,由于医疗保健投资的增加,北美地区预计将呈现最高的复合年增长率。辅助科技和居家照护解决方案的进步正在推动需求,从而改善失智症患者的生活品质。政府措施和医疗保健提供者的大力支持进一步推动了市场成长。该地区强大的基础设施和创新生态系统也促进了有效失智症护理产品的开发和应用,有助于市场持续扩张。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一:

  • 公司简介
    • 全面分析其他市场参与者(最多 3 家公司)
    • 主要企业的SWOT分析(最多3家公司)
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球失智症护理产品市场(按产品)

  • 记忆训练和活动产品
  • 药物管理产品
  • 每日提醒产品
  • 浴室安全产品
  • 进食辅助器
  • 治疗设备
  • 认知训练工具
  • 行动支援产品
  • 个人安全设备
  • 沟通辅助工具
  • 失禁用品
  • 其他产品

6. 全球失智症护理产品市场(按分销管道)

  • 网路零售
  • 药局
  • 专卖店
  • 超级市场/大卖场
  • 直销

7. 全球失智症护理产品市场(按最终用户划分)

  • 居家照护环境
  • 长期照护中心
  • 医院
  • 生活协助设施
  • 养老院
  • 其他最终用户

8. 全球失智症护理产品市场(按地区)

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Eli Lilly and Company
  • Biogen Inc.
  • Johnson & Johnson
  • Philips Healthcare
  • GE Healthcare
  • Medline Industries, Inc.
  • Cardinal Health, Inc.
  • AbbVie Inc.
  • Roche Holding AG
  • AstraZeneca PLC
  • Sanofi SA
  • Merck & Co., Inc.
  • Amgen Inc.
  • Pfizer Inc.
  • Lundbeck A/S
  • GSK plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Beurer GmbH
  • Doro AB
Product Code: SMRC29612

According to Stratistics MRC, the Global Dementia Care Products Market is accounted for $27.07 million in 2025 and is expected to reach $47.61 million by 2032 growing at a CAGR of 8.4% during the forecast period. Dementia care products are specialized tools, devices, and aids designed to support individuals living with dementia and improve their quality of life. These products promote safety, independence, comfort, and cognitive support, both at home and in care settings. Common examples include memory aids, orientation clocks, adaptive clothing, GPS trackers, sensory therapy tools, and easy-to-use household items. They help reduce confusion, prevent wandering, manage agitation, and assist with daily living activities. Dementia care products also support caregivers by making care tasks easier and more effective, ultimately enhancing the overall well-being and dignity of those affected by cognitive decline.

According to the World Health Organization, approximately 55 million people worldwide will be living with dementia in 2023, with projections indicating this number will rise to 57 million by 2024.

Market Dynamics:

Driver:

Rising Global Dementia Prevalence

The rising global prevalence of dementia is driving significant growth in the dementia care products market. As more individuals and families face the challenges of memory loss and cognitive decline, demand increases for innovative, effective solutions that enhance quality of life and ease caregiving. This surge fuels research, product development, and technological advancements in assistive devices, safety tools, and daily living aids. Consequently, the market experiences a positive, forward-driving momentum, attracting investments and fostering global awareness around dementia care needs.

Restraint:

High Costs of Specialized Products

High costs of specialized dementia care products create significant barriers for many families, limiting access to essential tools and technologies. This financial burden reduces market demand, slowing innovation and product development. Additionally, high prices can widen health disparities, as lower-income individuals struggle to afford quality care solutions. Consequently, the market growth is hindered, and overall dementia care quality may decline due to restricted availability and adoption of advanced, specialized products.

Opportunity:

Technological Advancements in Care Products

Technological advancements in care products are absolutely transforming the dementia care products market by enhancing patient safety, improving caregiver efficiency, and enabling personalized care. Innovations such as wearable health monitors, GPS tracking devices, and AI-powered cognitive aids support early detection and better management of symptoms. These technologies also reduce caregiver burden and increase independence for individuals with dementia. As a result, demand for smart, tech-integrated solutions is driving market growth and encouraging further innovation in dementia care.

Threat:

Regulatory Challenges

Regulatory challenges significantly hinder the dementia care products market by causing delays in product approvals and increasing development costs. Strict compliance requirements create barriers for innovation, limiting the introduction of advanced care solutions. These hurdles also discourage investment and slow market growth, restricting access to effective products for patients. Additionally, varying regulations across regions complicate global distribution, further impeding timely availability and adoption of essential dementia care technologies.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the dementia care products market by disrupting supply chains and limiting patient access to essential care items. Lockdowns and healthcare system strains led to reduce in-person support, increasing demand for home-based care solutions. However, heightened awareness of vulnerable populations, like those with dementia, drove innovation and adoption of remote monitoring and assistive technologies, ultimately reshaping care delivery and accelerating market growth post-pandemic.

The cognitive training tools segment is expected to be the largest during the forecast period

The cognitive training tools segment is expected to account for the largest market share during the forecast period as it offers non-invasive solutions that enhance cognitive function and slow disease progression. These tools support memory, attention, and problem-solving skills, complementing medical treatments and promoting independence. Increased adoption in home and institutional settings reflects growing recognition of non-pharmacological interventions. With rising dementia prevalence, the demand for innovative, evidence-based cognitive training solutions is boosting market growth and shaping a more holistic approach to dementia care.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, because of demand for advanced care solutions. Hospitals serve as key centers for diagnosis, treatment, and long-term care, thereby fostering adoption of innovative products such as cognitive aids, monitoring devices, and personal care tools. Their emphasis on patient safety, standardized care, and caregiver support further boosts market growth. Additionally, hospital-based research initiatives and collaborations accelerate product development, enhancing overall dementia care quality and accessibility.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising awareness, growing elderly populations, and improved healthcare infrastructure. Innovations in assistive technologies and supportive government initiatives are enhancing patient care and independence. Increasing investments by regional players and collaborations with global firms are accelerating product availability and affordability. These developments are not only improving quality of life for dementia patients but also creating significant economic and employment opportunities across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increased healthcare investment. Advancements in assistive technologies and home-based care solutions are boosting demand, enabling better quality of life for dementia patients. Government initiatives and strong support from healthcare providers further accelerate market growth. The region's robust infrastructure and innovation ecosystem also foster the development and adoption of effective dementia care products, propelling sustained market expansion.

Key players in the market

Some of the key players profiled in the Dementia Care Products Market include Eli Lilly and Company, Biogen Inc., Johnson & Johnson, Philips Healthcare, GE Healthcare, Medline Industries, Inc., Cardinal Health, Inc., AbbVie Inc., Roche Holding AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Amgen Inc., Pfizer Inc., Lundbeck A/S, GSK plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Beurer GmbH and Doro AB.

Key Developments:

In April 2025, GE HealthCare and FPT Corporation have expanded their strategic partnership to accelerate AI-driven healthcare innovation. This collaboration includes the establishment of an FPT Competency Center in Vietnam, aimed at enhancing product strategy, development, and customer onboarding within GE HealthCare's digital ecosystem.

In March 2025, NVIDIA and GE HealthCare have announced a collaboration to advance autonomous diagnostic imaging, focusing on developing AI-driven X-ray and ultrasound technologies. This partnership aims to address the global shortage of radiology professionals and improve access to medical imaging services.

In January 2025, Sutter Health and GE HealthCare have entered into a seven-year strategic partnership, known as the "Care Alliance," aimed at enhancing diagnostic imaging services across California.

Products Covered:

  • Memory Exercise & Activity Products
  • Medication Management Products
  • Daily Reminder Products
  • Bathroom Safety Products
  • Dining Aids
  • Therapeutic Devices
  • Cognitive Training Tools
  • Mobility Assistance Products
  • Personal Safety Devices
  • Communication Aids
  • Incontinence Products
  • Other Products

Distribution Channels Covered:

  • Online Retail
  • Pharmacies
  • Specialty Stores
  • Supermarkets/Hypermarkets
  • Direct Sales

End Users Covered:

  • Home Care Settings
  • Long-term Care Centers
  • Hospitals
  • Assisted Living Facilities
  • Nursing Homes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dementia Care Products Market, By Product

  • 5.1 Introduction
  • 5.2 Memory Exercise & Activity Products
  • 5.3 Medication Management Products
  • 5.4 Daily Reminder Products
  • 5.5 Bathroom Safety Products
  • 5.6 Dining Aids
  • 5.7 Therapeutic Devices
  • 5.8 Cognitive Training Tools
  • 5.9 Mobility Assistance Products
  • 5.10 Personal Safety Devices
  • 5.11 Communication Aids
  • 5.12 Incontinence Products
  • 5.13 Other Products

6 Global Dementia Care Products Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Online Retail
  • 6.3 Pharmacies
  • 6.4 Specialty Stores
  • 6.5 Supermarkets/Hypermarkets
  • 6.6 Direct Sales

7 Global Dementia Care Products Market, By End User

  • 7.1 Introduction
  • 7.2 Home Care Settings
  • 7.3 Long-term Care Centers
  • 7.4 Hospitals
  • 7.5 Assisted Living Facilities
  • 7.6 Nursing Homes
  • 7.7 Other End Users

8 Global Dementia Care Products Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Eli Lilly and Company
  • 10.2 Biogen Inc.
  • 10.3 Johnson & Johnson
  • 10.4 Philips Healthcare
  • 10.5 GE Healthcare
  • 10.6 Medline Industries, Inc.
  • 10.7 Cardinal Health, Inc.
  • 10.8 AbbVie Inc.
  • 10.9 Roche Holding AG
  • 10.10 AstraZeneca PLC
  • 10.11 Sanofi S.A.
  • 10.12 Merck & Co., Inc.
  • 10.13 Amgen Inc.
  • 10.14 Pfizer Inc.
  • 10.15 Lundbeck A/S
  • 10.16 GSK plc
  • 10.17 Novartis AG
  • 10.18 Teva Pharmaceutical Industries Ltd.
  • 10.19 Beurer GmbH
  • 10.20 Doro AB

List of Tables

  • Table 1 Global Dementia Care Products Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Dementia Care Products Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Dementia Care Products Market Outlook, By Memory Exercise & Activity Products (2024-2032) ($MN)
  • Table 4 Global Dementia Care Products Market Outlook, By Medication Management Products (2024-2032) ($MN)
  • Table 5 Global Dementia Care Products Market Outlook, By Daily Reminder Products (2024-2032) ($MN)
  • Table 6 Global Dementia Care Products Market Outlook, By Bathroom Safety Products (2024-2032) ($MN)
  • Table 7 Global Dementia Care Products Market Outlook, By Dining Aids (2024-2032) ($MN)
  • Table 8 Global Dementia Care Products Market Outlook, By Therapeutic Devices (2024-2032) ($MN)
  • Table 9 Global Dementia Care Products Market Outlook, By Cognitive Training Tools (2024-2032) ($MN)
  • Table 10 Global Dementia Care Products Market Outlook, By Mobility Assistance Products (2024-2032) ($MN)
  • Table 8 Global Dementia Care Products Market Outlook, By Personal Safety Devices (2024-2032) ($MN)
  • Table 12 Global Dementia Care Products Market Outlook, By Communication Aids (2024-2032) ($MN)
  • Table 13 Global Dementia Care Products Market Outlook, By Incontinence Products (2024-2032) ($MN)
  • Table 14 Global Dementia Care Products Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 15 Global Dementia Care Products Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Dementia Care Products Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 17 Global Dementia Care Products Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 18 Global Dementia Care Products Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 19 Global Dementia Care Products Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 20 Global Dementia Care Products Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 21 Global Dementia Care Products Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Dementia Care Products Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 23 Global Dementia Care Products Market Outlook, By Long-term Care Centers (2024-2032) ($MN)
  • Table 24 Global Dementia Care Products Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 25 Global Dementia Care Products Market Outlook, By Assisted Living Facilities (2024-2032) ($MN)
  • Table 26 Global Dementia Care Products Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 27 Global Dementia Care Products Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.